65--FLUENCY COVERED STENT GRAFT

The National Naval Medical Center's Acquisition Management Department in Bethesda, Maryland, acting on behalf of the Radiology and Special Procedures Departments, plans to issue a sole-source commercial purchase order to Bard Peripheral Vascular, a division of C.R. Bard Corporation. The procurement involves Fluency Covered Stent Grafts, which are specifically designed for exclusive use with Bard Peripheral Vascular's deployment system, ensuring compatibility and performance. This contract reflects a specialized acquisition approach, bypassing competitive bidding due to the proprietary nature of the equipment. This presolicitation, identified by solicitation number Reference-Number-N0016804RCNY006, was posted on June 8, 2004, under the NAICS code 339113, which pertains to surgical and medical instrument manufacturing. The contract is managed within the Department of Defense framework, specifically under the Walter Reed National agency office. The place of performance is associated with Bethesda, Maryland, reinforcing the local operational focus of the acquisition. The sole-source nature underscores the intent to maintain consistency and reliability in medical treatment capabilities within the naval medical services.